OpenNashPodcasts

Person

Matt Pillar

3 episodes · 4 quoted claims

Host Matt Pillar said venture investor Bruce Booth's year-in-review identified roughly 110 companies targeting CD19.

“he identified more than I think 110 companies targeting CD19.”

Business Of Biotech · 0:33:29

The Business of Biotech podcast, produced in partnership with Cytiva, was marking its one-year anniversary at the time of this episode.

“we will be celebrating our one-year anniversary of the Business of Biotech podcast, which coincides with the one-year anniversary of our partner and its production, Cytiva.”

Business Of Biotech · 0:00:19

Matt Pillar says he recently interviewed Dietrich Stefan, CEO of New Base Therapeutics, on the podcast about fail-fast, fail-cheap thinking.

“I recently had a conversation on this podcast with Dietrich Stefan, who's the CEO at New Base Therapeutics.”

Business Of Biotech · 0:25:10

Matt Pillar says he ran track in high school and college and was a 400-meter intermediate hurdler.

“I was a runner in high school and college and I had a track coach in college.”

Business Of Biotech · 0:30:30